Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · IEX Real-Time Price · USD
5.11
+0.10 (2.00%)
At close: May 31, 2024, 4:00 PM
5.30
+0.18 (3.62%)
After-hours: May 31, 2024, 6:06 PM EDT
Vanda Pharmaceuticals Market Cap
Vanda Pharmaceuticals has a market cap or net worth of $297.39 million as of May 31, 2024. Its market cap has decreased by -15.27% in one year.
Market Cap
297.39M
Enterprise Value
-90.23M
1-Year Change
-15.27%
Ranking
Category
Stock Price
$5.11
Market Cap Chart
Since April 12, 2006, Vanda Pharmaceuticals's market cap has increased from $209.50M to $297.39M, an increase of 41.95%. That is a compound annual growth rate of 1.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 31, 2024 | 297.40M | 1.99% |
| May 30, 2024 | 291.60M | 1.85% |
| May 29, 2024 | 286.30M | -1.21% |
| May 28, 2024 | 289.80M | -4.80% |
| May 24, 2024 | 304.40M | 6.51% |
| May 23, 2024 | 285.80M | -4.45% |
| May 22, 2024 | 299.10M | 0.57% |
| May 21, 2024 | 297.40M | -3.03% |
| May 20, 2024 | 306.70M | -3.83% |
| May 17, 2024 | 318.90M | -1.79% |
| May 16, 2024 | 324.70M | 4.10% |
| May 15, 2024 | 311.90M | 4.45% |
| May 14, 2024 | 298.60M | 1.60% |
| May 13, 2024 | 293.90M | 0.20% |
| May 10, 2024 | 293.30M | 0.58% |
| May 9, 2024 | 291.60M | -5.45% |
| May 8, 2024 | 308.40M | -2.19% |
| May 7, 2024 | 315.30M | 13.21% |
| May 6, 2024 | 278.50M | -0.82% |
| May 3, 2024 | 280.80M | 4.27% |
| May 2, 2024 | 269.30M | -1.89% |
| May 1, 2024 | 274.50M | 0.22% |
| Apr 30, 2024 | 273.90M | -1.23% |
| Apr 29, 2024 | 277.30M | 4.33% |
| Apr 26, 2024 | 265.80M | 3.10% |
View and export this data all the way back to 2006.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ESSA Pharma | 299.45M |
| Emergent BioSolutions | 298.69M |
| AxoGen | 298.50M |
| Inozyme Pharma | 298.14M |
| DocGo | 297.59M |
| Revance Therapeutics | 296.63M |
| Sharecare | 295.11M |
| Poseida Therapeutics | 289.90M |